Strides Pharma Science Limited has informed the Exchange regarding a press release dated March 15, 2021, titled "Strides receives USFDA approval for Potassium Chloride for Oral Solution".
Press Release Mar 15 2021
Filed with NSE ·
6ix hasn’t read this filing yet.
Strides Pharma Science Ltd on 6ix
Earlier from Strides Pharma Science
- Press Release Feb 24 2021
- Press Release Feb 12 2021
- Press Release Feb 04 2021
- Press Release Jan 25 2021
- Press Release Jan 15 2021
Later from Strides Pharma Science
- Press Release Mar 19 2021
- Press Release May 27 2021
- Press Release Jun 14 2021
- Press Release Jun 28 2021
- Press Release Aug 06 2021
Follow Strides Pharma Science into a list and get an email when it puts out news.
Follow Strides Pharma Science